Galectins regulate a wide variety of biological processes. However, one of the earliest and most common galectin activities is likely their ability to recognize microbes. Galectin binding to microbes can result in direct microbial killing and activation of host immunity, eventually enhancing the ability of a host to eliminate microbes. However, microbes appear to have also evolved the ability to utilize galectins to enhance host attachment, ultimately leading to increased risk for infection. The ability of galectins to directly engage microbes, coupled with their role in regulating host immune function, positions these carbohydrate binding proteins as key factors that can dictate the consequence of microbial exposure. In this way, galectins represent a highly pleiotropic protein family involved in the regulation of a broad range of host-microbial interactions.
A. Introduction
Host pathogen interactions fundamentally shape a broad range of biological processes. While products of microbial metabolism can impact a wide variety of host activities, from neurological function to overall metabolism and immune homeostasis (1-3), direct interactions between host and microbes can fundamentally shape microbial flora, impact immune function and often ultimately dictate the likelihood of infectious disease (4) . Although host factors can interact with a variety of distinct microbial molecular determinants, cell surface glycans represent the most unique, diverse and rich molecular features that decorate microbes (5, 6) . As microbial carbohydrate determinants often completely envelope microbes, these structures often represent the first and most significant molecular signature encountered by a host. As a result, hosts appear to have evolved a variety of immune factors that possess the ability to recognize the distinct carbohydrate signature of a broad range of organisms (6) (7) (8) (9) . Indeed, many immune populations are defined by the distinct repertoire of glycan binding proteins (GBPs) they express (6) (7) (8) , strongly suggesting that microbial glycan-host interactions may result in the engagement of specific immune cells and thus shape host immunity in fundamental ways.
B. Discovery of Galectins
Prior to studies that demonstrated the importance of host recognition of microbial glycans in shaping host immunity, the role of cell surface carbohydrates in general remained elusive for many years (10) . However, subsequent studies began demonstrating that glycans can regulate a wide variety of fundamental biological processes (11) (12) (13) . More specifically, the discovery of GBPs provided a potential mechanism of translating a cell surface glycan code into biologically meaningful outcomes (13) . The discovery of mammalian GBPs also provided a mechanism whereby hosts may recognize and therefore respond to distinct microbes through recognition of their unique glycan determinants (5) . Indeed, while the vast majority of early studies on GBP function focused primarily on GBP regulation of mammalian cell biology, the ability of GBPs to not only bind microbial glycans, but in some cases, exclusively recognize the glycan determinants of microbes, has become a focus GBP studies (5, 9, (14) (15) (16) (17) (18) (19) . While the microbial glycan specificity of many of these GBPs remains to be defined, GBP-microbial glycan interactions represent a fundamental aspect of host-microbial interactions.
Although the ability of plants to express GBPs was recognized in the 19th century, the potential existence of mammalian GBPs was actually quite controversial for many years. It wasn't until Ashwell and Morrell observed that desiaylated proteins were rapidly cleared in the liver that a potential mammalian GBP activity and therefore target was identified (20) . Subsequent studies identified the potential receptor responsible for the removal of desialylated glycoproteins and in so doing characterized the asialoglycoprotein receptor (21, 22) , the first example of a mammalian GBP. Despite the fact that the actual function of the asialoglycoprotein receptor would not be recognized until decades later (11) , this discovery launched efforts by several labs to determine whether additional GBPs exist in vertebrates. Using similar biochemical approaches, in 1975 Teichberg and colleagues isolated the next vertebrate GBP described from the electric organ of the electric eel Electrophorus electricus (23) . Coined electrolectin, the electric eel GBP was the first galectin discovered and was soon followed thereafter by similar proteins isolated by the laboratories of Bar-MINIREVIEW doi: 10.4052/tigg.1738.1SE
(Article for special issue on Galectins) SE186 ondes and Kornfeld from chicken and bovine sources, respectively (23) (24) (25) . Currently, fifteen members of the galectin family (Gal-1 through -15) have been described in mammals (eleven in humans), ranging from 14-39 kDa in subunit size (26) (Fig. 1) .
Although the discovery of galectins demonstrated that additional GBPs exist in mammals, the physiological role of galectins remained elusive for many years. The majority of early studies on galectins focused on the biochemical properties of galectin family members (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) . These early studies demonstrated that galectins possess a common affinity for β-galactosides. In addition, several galectins appeared to exhibit a unique sensitivity toward oxidative inactivation (37) (38) (39) (40) (41) . As a result, early nomenclature that defined mammalian GBPs originally categorized galectins as S-type lectins in an effort to emphasize their unique dependence on reduced thiols for activity (in contrast to C-type lectins, which require Ca 2+ ) (27, 36, (42) (43) (44) . As subsequent studies demonstrated that not all galectins exhibit sensitivity to oxidative inactivation, yet continued to share β-galactoside preferences (45, 46) , the term galectins was used to describe a common feature of this protein family (47).
Thus, while subsequent studies have demonstrated that individual galectin family members can exhibit very distinct glycan binding patterns (28) (29) (30) (48) (49) (50) , galectins have historically consisted of a family of proteins characterized by an ability to bind β-galactosides.
C. Galectins and Immunity
In an effort to understand the function of galectins in vivo, early studies first examined galectin localization in tissue. While many of these studies demonstrated that galectins can exhibit differential expression during development, particularly within developing muscle tissue, several studies also demonstrated that galectin-1 exhibits significant localization within neuromuscular junctions (51) (52) (53) . To determine whether exogenous administration of galectin-1 might favorably impact neuromuscular junction activity, Teichberg and colleagues employed a model of myasthenia gravis. Consistent with the potential involvement of galectin in the neuromuscular junction, injection of exogenous galectin-1 significantly improved muscle function. However, further investigation demonstrated that the ability of galectin-1 to alter muscle activity did not actually reflect direct alterations in neuromuscular endplate function, but instead resulted from the ability of galectin-1 to suppress the immune response needed to generate the myasthenia gravis model (54) . Subsequent studies conducted by Offner and colleagues demonstrated that delivery of recombinant galectin-1 could also reduce adverse clinical sequelae in a model experimental autoimmune encephalomyelitis (55) , a commonly employed model to study galectin function in later studies (56) . Additional studies similarly demonstrated that administration of galectin-1 could positivity impact disease progression in models of hepatitis, colitis, nephritis and arthritis (57) (58) (59) (60) . These results suggested that galectin-1 in particular may regulate fundamental aspects of general immune function and provided some of the first insight into the biological roles of galectins in vivo. Many studies have now corroborated the notion that galectin-1 not only regulates immune function (56, 61, 62) , but that nearly every galectin family member possesses the ability to modify some aspect of immunity through engagement of a variety of cell types and through a broad range of mechanisms (35, (63) (64) (65) (66) (67) (68) (69) .
While early studies examining galectin function primarily utilized models of autoimmunity, subsequent studies focused on the potential role of galectins in regulating immune responses following infectious challenge (70) (71) (72) . These results suggested that galectins may serve as potent activators of innate immune cells and be critical in the orchestration of an effective adaptive immune response following microbial challenge (68) . However, several studies also demonstrated that galectins might directly engage microbes (73) (74) (75) , suggesting that galectins may more intimately regulate host response to microbial challenge. These results suggested that in addition to binding endogenous ligands, galectins may actually engage a variety of microbial carbohydrate determinants (5, (15) (16) (17) (18) (19) . Furthermore, as galectins are soluble proteins, unlike most pattern recognition receptors with lectin activity that possess terminal carbohydrate recognition domains as part of a larger transmembrane protein, galectins appeared to be uniquely poised to directly engage microbes in a wide variety of settings (76) . In this review, we will describe galectin interactions with potential pathogens by characterizing these interactions into broad categories, including examination of galectin interactions with bacteria, viruses, protozoa, trematodes, nematodes and fungi. In doing so, we will not provide an exhaustive review of the literature describing all known galectin-microbial interactions. Furthermore, while galectins regulate a wide variety of host immune factors with consequences on immune responsiveness to infectious challenge, we will not focus on aspects of galectin-mediated regulation of host immunity that impact the outcome of microbial exposure, which has been extensively reviewed elsewhere (6, 7, 77) . Instead, we will provide examples of galectin engagement of microbes that highlight the diverse nature and consequences that these interactions can have on host-microbial exposure.
D. Galectin Interactions with Bacteria
Despite significant interest in the potential roles galectins may play in the regulation of immune function, early studies also began examining the possible role of galectins to regulating host microbial interactions by directly engaging microbial glycans (78) (Fig. 2) . Early studies demonstrated that galectin-3 recognizes lipopolysaccharides (LPS) isolated from Klebsiella pneumoniae and Pseudomonas aeruginosa through carbohydrate dependent interactions (73, 74) . Subsequent studies similarly demonstrated that galectin-3 could interact with the carbohydrate motifs of LPS isolated from Neisseria gonorrhoeae, Neisseria meningitidis and Helicobacter pylori (79) (80) (81) . Importantly, examination of interactions between galectin-3 and N. meningitidis suggested that this interaction might be specific to galectin-3, as galectin-1 and galectin-4 failed to display similar binding in parallel studies. Furthermore, while interactions between galectin-3 and N. meningitidis LPS were inhibited by lactose, suggesting a carbohydrate-dependent binding event, galectin-3 engagement of N. meningitidis LPS required full-length galectin-3, as the carbohydrate recognition domain (CRD) alone of galectin-3 failed to display similar binding (80) , suggesting that additional carbohydrate-independent interactions may occur. Consistent with this, galectin-3 interactions with LPS isolated from the Salmonella enterica ssp. S. enterica serovar S. minnesota R7 strain occurred through carbohydrate-independent interactions (73) . Furthermore, although the CRD was responsible for the carbohydrate-dependent interactions observed between galectin-3 and the LPS of K. pneumoniae, the N-terminal, collagenlike domain was shown to be responsible for non-carbohydrate LPS interactions (73) . These studies demonstrate that galectins can en- . LPS engagement by galectins can reflect carbohydrate-dependent, carbohydrate-independent or both carbohydrate-dependent and -independent interactions. Some galectin interactions with bacteria result in microbial death, while others have not been formally tested or fail to directly impact microbial viability. Galectin interactions with bacteria can facilitate host detection and response, while some bacteria appear to utilize these interactions as a mechanism of host attachment and infection. Red arrows indicate that the activity is increased by the respective galectin, while blue arrows represent an activity that the indicated galectin decreases.
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gage key molecular determinants of bacteria, but that these interactions may be more complex than simple carbohydrate recognition. 
E. Galectin Interactions with Viruses
In parallel with early studies describing potential interactions between galectin-3 and bacterial LPS, several studies began examining the potential impact of galectins on viral infection ( which is a Rhabdovirdidae that infects teleost fish (such as salmon and trout), prevents its ability to induce infection (122, 123) .
F. Galectin Interactions with Protozoa, Trematodes and Nematodes
Early studies examining the potential role of galectins in regulating host-parasite interactions focused on the ability of galectin-3
to potentiate parasite engagement of host (Fig. 4) . These studies mansoni infection (128, 129) , no difference in the worm burden or overall numbers of eggs in the liver or intestine could be detected in galectin-3 KO versus WT controls (128) . As a result, future studies will be needed to define the consequences of galectin-3-S. mansoni 
G. Galectin Interactions with Fungi
While a number of studies have examined potential interactions between galectins and a variety of different microbes, less is known about the role of galectins in directly detecting and regulating interactions with fungal organisms (Fig. 5) . The earli- exists in vivo (153) . Indeed, galectin-3 KO mice experience increased C. neoformans burden and mortality following infection.
Galectin-3 KO mice also displayed significant changes in key proinflammatory cytokines, including downregulation of IL-6, IL-12
and TNFα. As a result, the reduced ability of galectin-3 KO mice to clear C. neoformans may reflect both direct galectin-3-mediated effects on C. neoformans viability and the ability of galectin-3 to induce an optimal pro-inflammatory immune program following C.
neoformans challenge (153) .
H. Conclusions
Given Additional studies will be needed to characterize the overall specificity of galectin family members for microbial glycans. The ability of galectins to not only recognize microbes, but also regulate immune function, in addition to a wide variety of other biological processes through both carbohydrate-dependent and independent mechanisms, makes the galectin family one of the most pleiotropic protein families described. As this diversity of function can make the study of galectins challenging, future studies will need to use a variety of approaches and model organisms to dissect the role of individual galectin family members in directly regulating host interactions with microbes.
